Pyxis Oncology (PYXS) had its price target lowered by Stifel Nicolaus from $9.00 to $8.00. They now have a "buy" rating on the stock.
Pyxis Oncology (PYXS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $7.00 price target on the stock.
Pyxis Oncology GAAP EPS of -$1.28 misses by $0.93, revenue of $13.9M [Seeking Alpha]
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results